Category:
Preclinical Research Services
CAS NO:
1177261-73-2
Standard:
ChP,
Terazosin is a quinazoline derivative used as an antihypertensive agent. Synthesized via condensation of 4,5-dimethoxy-2-nitrobenzoic acid with hydrazine, it acts as a selective alpha-1 adrenergic antagonist. Molecular Formula: C19H25N5O4; CAS No.: 77777-68-1.
Contraindicated in patients with severe hepatic impairment. Store in a cool, dry place below 25°C protected from light. Handle with appropriate PPE to avoid skin contact or inhalation of dust particles.